Get 20% lifetime commission for referring investors to digrin.com
here.
Graphite Bio, Inc. (GRPH) Financials
Stock symbol GRPH is outdated, potentially delisted? Maybe it is available on other exchange?
GRPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 188.5 million | 4.9 million |
| Sept. 30, 2023 | 266.2 million | 62.2 million |
| June 30, 2023 | 287.0 million | 62.9 million |
| March 31, 2023 | 310.0 million | 33.8 million |
GRPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -45.9 million | 2.3 million |
| Sept. 30, 2023 | -14.2 million | 2.2 million |
| June 30, 2023 | -19.3 million | 2.8 million |
| March 31, 2023 | -21.5 million | 3.3 million |
GRPH Net Income
No data available :(
GRPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 185.9 million | - | 362000 |
| Sept. 30, 2023 | 234.0 million | - | 53.1 million |
| June 30, 2023 | 246.7 million | - | 53.5 million |
| March 31, 2023 | 264.1 million | - | 4.5 million |
GRPH Shares Outstanding
GRPH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 50000 | 1000 | 14.6 million | 142000 |
| Sept. 30, 2023 | 4.8 million | 2.4 million | 11.3 million | - |
| June 30, 2023 | 5.6 million | 13.5 million | 7.5 million | - |
| March 31, 2023 | 383000 | 16.2 million | 7.6 million | - |
GRPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 10.2 million | 142000 |
| Sept. 30, 2023 | - | 800000 |
| June 30, 2023 | - | 2.1 million |
| March 31, 2023 | - | 2.2 million |
GRPH
Price: $3.18
52 week price:
Forward Dividend Yield: 32.39%
Dividend Per Share: 1.03 USD
Earnings Per Share: -2.23 USD
P/E Ratio: -1.37
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 124104
Market Capitalization: 189.8 million
Years Paying Dividends: 1